Q&A: The New Normal: Considerations for Restarting Research
In a recent webinar, Advarra IRB and research compliance experts discussed key areas to consider when ramping up research in the COVID-19 pandemic’s “new normal.”
7 Staff Augmentation Resources to Help Your Site Restart Research
With research activities gradually resuming, research teams may be challenged with conducting their trials effectively and efficiently. Here’s how Staff Augmentation can help.
Q&A: Gene Therapy Research in the Age of COVID-19: Study Startup for Infectious Disease, Oncology, and Rare Disease Research
In Advarra’s inaugural virtual symposium, experts from industry and academia met to discuss the unique challenges gene therapy research poses for research sites, sponsors, CROs, and study participants.
Improving Site-Sponsor Relationships Leads to Transparent Clinical Trials
The site-sponsor relationship is a multi-faceted one. The need for communication and understanding between the two is prevalent now more than ever.
Bringing the Gene Therapy Conversation to You – Virtually
On June 3, members of the research community gathered virtually to discuss updates on hot topics and emerging issues in gene therapy.
For Sponsors and Sites, the Research Restart Effort Begins with Communication
The global pandemic has changed the way we think about research. Sponsors should consider how the “new normal” will impact sites and current studies as they plan to re-start research.
Safety Precautions for Laboratory Research With COVID-19 Specimens
Biosafety has surged to the spotlight due to the current COVID-19 global pandemic, motivating sites to conduct a risk assessment and develop a risk mitigation plan.
Spring Onsemble Conference: Gathering, Collaborating and Learning Virtually
Earlier in May, members of the Onsemble Community gathered to learn and share best practices online during the Virtual Onsemble Conference
4 Essential Skills for the Ideal Clinical Trial Project Manager
Learn how to find the right individual to manage your clinical research projects and improve the efficiency of your clinical trials.
Trial Design in the Time of COVID-19: Complex and Efficient
While the clinical research community is currently being challenged by the COVID-19 pandemic, adaptive and platform study designs may provide much-needed help for sites.